Revenio Group Oyj - Company Announcement

Revenio Group Corporation: BOARD DECIDED ON A CAPITAL REPAYMENT OF EUR 0.12 PER SHARE

Revenio Group Oyj Stock Exchange Release, August 5, 2013 at 8.50 a.m.

REVENIO GROUP CORPORATION'S BOARD DECIDED ON A CAPITAL REPAYMENT OF EUR 0.12 PER
SHARE

The Annual General Meeting of Revenio Group Corporation on  March 21st
authorized the Board of Directors to decide on, at its own discretion, a capital
repayment from the invested unrestricted equity reserve. The
maximum amount of equity distributed to shareholders on the basis of the
authorization would be EUR 1,000,000.00.

Based on this authorization, The Board has today decided on a capital repayment
of EUR 0.12 per share. This decision is based on the favourable development of
the company's result and financial position as well as maintaining the company's
capital structure in line with the set financial targets.

The total of capital repayment is EUR 940,026.12. The Board will not decide any
further repayments based on this authorization.

The capital repayment ex-date is August 5(th), 2013 and it will be paid to
shareholders listed in the company's share register maintained by Euroclear
Finland on  August 8(th) 2013. The payment will be paid out starting on August
15(th), 2013.

Capital repayment will also effect on the Revenio Group Corporation 2007 stock
options by reducing the strike price of the series 2007B stock options to EUR
2.35 and series 2007C stock options to EUR 2.29.

Olli-Pekka Salovaara
President and CEO

For further information, please contact:

CFO Pekka Raatikainen,
+358 (0)50 553 4094 (mobile)
pekka.raatikainen@revenio.fi
http://www.revenio.fi/

DISTRIBUTION:

NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Key media
www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish health tech group whose core business are tonometers. The
Revenio Health Tech segment comprises the operations of Icare Finland Oy. The
widely patented Icare product family is the current cornerstone of the Group's
success. Revenio seeks vigorous growth in health technology, both organically
and through acquisitions and mergers.

The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry. These businesses are extremely profitable in their
industries and generate positive cash flow.

In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its
operating margin standing at 19.4 percent. The Revenio Group Corporation is
listed on NASDAQ OMX Helsinki.




[HUG#1721072]